NCT02130193 · Interventional trial
Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations
Overall registry status Completed
Phase 2
Conditions Pulmonary Disease, Chronic Obstructive
Delaware Valley sites
- GSK Investigational Site · Oaks, PA · Montgomery County
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory